# FDA recall D1292-2014

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2014-03-24.

## Product

METHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960,  NDC 0093-2932-01

## Reason for recall

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements

## Distribution

Nationwide

## Key facts

- **Recall number:** D1292-2014
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-03-24
- **Report date:** 2014-05-21
- **Termination date:** 2014-11-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Horsham, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D1292-2014

## Citation

> AI Analytics. FDA recall D1292-2014. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D1292-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*